GND-323

N/A

Report date: 2025/01/23 11:41:30
NME

Base Information

Drug NameGND-323
Drug Alias NameGND-323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-protein interaction modulators
TargetsProtein-protein interaction
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGandeeva Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A